Drawing for ACCELLTA

USPTO serial 79372276

ACCELLTA

Reviewed by CopyMark Law Group

Reg. 7682951Status 700Registered
Filing date
Status date
Registration date
Feb 11, 2025
Examiner
SEVERSON, JUSTIN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ACCELLTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark I. Koffsky

Mark I. Koffsky Koffsky Schwalb LLC500 Seventh Avenue, 8th FloorNew York, NY 10018United States

Goods and services

ClassDescriptionStatusFirst use
001Raw materials for the food industry and for industrial use in the production of food products, namely, proteins, cells, biological tissues, lipids for use in food products, fatty acids, peptide substrates, animal cells, stem cells, animal tissues, gelatin, collagen, food additives; proteins, cells, tissues, lipids, peptides, animal cells, stem cells, animal tissues, gelatin, collagen, food additives, for industrial purposes; proteins, cells, tissues, fats, peptides, animal cells, stem cells, animal tissues, gelatin, collagen, food additives, for use in manufacture; proteins, cells, tissues, lipids, peptides, animal cells, stem cells, animal tissues, gelatin, collagen, food additives, for commercial or scientific use or in research; proteins, cells, tissues, fats, peptides, animal cells, stem cells, animal tissues, gelatin, collagen, for use in the food and food additives industry; proteins, cells, tissues, fats, peptides, animal cells, stem cells, animal tissues, gelatin, collagen, food additives, for use in the manufacture of animal foodstuffs and additives for animal foodstuffs; cell culture media for laboratory use, for research purposes, for industrial use or for use in production; cell culture media, other than for medical or veterinary use, namely, cell culture media for laboratory use and for use in the production of foodACTIVE—
005Pharmaceutical and veterinary preparations for use in tissue engineering and regenerative medicine; cell culture media for medical use; cell culture media for veterinary use; pharmaceutical preparations, sanitary preparations and dietetic preparations adapted for medical purposes; engineered biological tissue cultures for medical purposes; pharmaceutical compositions containing stem cells for medical or veterinary use; recombinant human protein, being biochemical preparations for medical purposes for the treatment of obesity, diabetes and for use in post-microsurgical rehabilitation; tissue culture media, microbiological culture media, animal blood preparations, serums and tissue culture preparations for use in regenerative medicine and cell-based therapies for medical purposesACTIVE—
029Dairy products and dairy substitutes, namely, milk, cheese, butter, yoghurt and other milk products, namely, cream; cell-based milk protein supplements; milk products from cells grown in a laboratory, namely, milk, cheese, butter, yoghurt; seafood, not live; seafood substitutes; synthetic seafood, not live; cultured seafood, not live products; laboratory-grown seafood, not live products; edible fats for use in the industrial manufacture of foodstuff; meat, fish, not live, poultry and game; porkACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 27, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 27, 2025FIMPFINAL DISPOSITION PROCESSED—
May 11, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 24, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 24, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 7, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 2, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 1, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 20, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 20, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 21, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 21, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 21, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 11, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 11, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 10, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 10, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 10, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 4, 2024RFNTREFUSAL PROCESSED BY IB—
Feb 15, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 15, 2024RFRRREFUSAL PROCESSED BY MPU—
Jan 27, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 26, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2024DOCKASSIGNED TO EXAMINER—
Jun 27, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 23, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 22, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance